Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3136775 | 1.00 | MAPT (0.39) | MAPTFFAR1 | |
| SCHEMBL3131652 | 0.86 | — | — | |
| SCHEMBL3131655 | 0.86 | — | — | |
| SCHEMBL3136008 | 0.82 | — | — | |
| SCHEMBL17243976 | 0.78 | MAPT (0.40) | MAPT | |
| SCHEMBL11432417 | 0.78 | FFAR1 (0.32) | FFAR1 | |
| SCHEMBL2837999 | 0.78 | MAPT (0.61) | MAPT | |
| SCHEMBL30002204 | 0.78 | MAPT (0.61) | MAPT | |
| SCHEMBL3134621 | 0.76 | ALOX15 (0.31) | FFAR1 | |
| SCHEMBL3134617 | 0.76 | ALOX15 (0.31) | FFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2864045-B1 | Use of a Lindlar type catalyst for the partial hydrogenation of 6-hydroxy-3-(5-hydroxy-3-methyl-pent-3-in-1-ynyl)-2,4,4-trimethylcyclohex-2-enone | DSM IP ASSETS BV (NL) | 2020-08-26 | — | — | EP | disclosed |
| WO-2018015525-A1 | 6-HYDROXY-3-[3-HYDROXY-3-METHYL-PENTA-1,4-DIENYL]-2,4,4-TRIMETHYL-CYCLOHEXA-2,5-DIEN-1-ONE | BASF SE (DE) | 2018-01-25 | — | — | WO | disclosed |
| EP-1697388-B1 | METHOD FOR PRODUCING PHOSPHONIUM SALTS | BASF SE (DE) | 2010-07-21 | — | — | EP | disclosed |
| US-7547807-B2 | Method for producing phosphonium salts | BASF SE (DE) | 2009-06-16 | — | — | US | disclosed |
| US-20070219383-A1 | Method for Reducing Alkyne Compuonds | BASF AKTIENGESELLSCHAFT (DE) | 2007-09-20 | — | — | US | disclosed |
| US-20070123726-A1 | Method for producing phosphonium salts | BASF AKTIENGESELLSCHAFT PATENTS, TRADEMARKS AND LICENSES (DE) | 2007-05-31 | — | — | US | disclosed |
| EP-1697388-A1 | METHOD FOR PRODUCING PHOSPHONIUM SALTS | BASF AKTIENGESELLSCHAFT (DE) | 2006-09-06 | — | — | EP | disclosed |
| WO-2005058924-A1 | METHOD FOR PRODUCING PHOSPHONIUM SALTS | BASF AKTIENGESELLSCHAFT (DE) | 2005-06-30 | — | — | WO | disclosed |
| US-5625099-A | Preparation of astaxanthin, novel intermediates therefor and the preparation thereof | ERNST HANSGEORG (DE) | 1997-04-29 | — | — | US | disclosed |
| US-5455362-A | Preparation of astaxanthin novel intermediates therefor and the preparation thereof | BASF AKTIENGESELLSCHAFT (DE) | 1995-10-03 | — | — | US | disclosed |
| US-4283559-A | Process for the manufacture of cyclohexene derivatives | HOFFMANN-LA ROCHE INC. (US) | 1981-08-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070123726-A1 | Method for producing phosphonium salts | PHOSPHO1, PLIN5, SQLE | MAPT 3742/4885FFAR1 698/4885 |
| US-20070219383-A1 | Method for Reducing Alkyne Compuonds | C9, C1S, C5 | MAPT 4742/4885FFAR1 3463/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.